Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

NCT07151040 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Colorectal Cancer (CRC)
Squamous Cell Carcinoma of Head and Neck
Non-Small Cell Lung Cancer (NSCLC)
Gastrooesophageal Junction Cancer
Gastric Cancer

Interventions

DRUG: TH9619

Sponsor

One-carbon Therapeutics AB